Search Results
Focal Adhesion Kinase Inhibition to Improve Losartan-Sunitinib Immunotherapy in Metastatic Osteo
Combination Therapies to Improve Immune-mediated Approaches for Osteosarcoma
Dosing and Combinations of Sunitinib vis-à-vis Alternative Therapies for RCC
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy
The Key Role of Focal Adhesion Kinase in Idiopathic Pulmonary Fibrosis
Daniel J. George, MD, regarding toxicity concerns when using sunitinib in RCC
Using RNA-nanoparticle Vaccines to Overcome Tumor Microenvironment of Canine Osteosarcoma
UHRF1 Expression Promotes Osteo Metastasis thru Altered Exosome Production & AMPK/SEMA3E Suppression
My Approach to Dosing Schedules for Sunitinib
Current Data on RCC Therapy: Sunitinib Dosing, Combination Therapy and More
Potential of Molecular-Driven Stratification for Osteosarcoma Treatment and Prognosis | Oncotarget
Study of Single-Agent Lenvatinib with Refractory/Relapsed Solid Malignancies & YA with Osteosarcoma
